The Crystal Structure of 2-Nitro-N-(4-nitrophenyl)benzamide
2-Nitro-N-(4-nitrophenyl)benzamide was synthesized and characterized by spectroscopy and elemental analysis. The crystal structure was determined from single-crystal X-ray diffraction data. It crystallizes in the orthorhombic space group, P 212121, with unit cell dimensions a = 8.9443(10) Å, b = 9.7147(11) Å, and c = 13.8016(16) Å. The dihedral angle between the 2 aromatic rings is 82.32(4)\circ. The N2 and N3 nitro groups are oriented with respect to their attached phenyl rings at dihedral angles of 1.97(3)\circ and 15.73(3)\circ, respectively. The intramolecular C-H{\ldots}O hydrogen bond results in the formation of a non-planar 6-membered ring. In the crystal structure, intermolecular N-H...O hydrogen bonds seem to be effective in the stabilization of the structure, resulting in the formation of a 3-dimensional network.
The Crystal Structure of 2-Nitro-N-(4-nitrophenyl)benzamide
2-Nitro-N-(4-nitrophenyl)benzamide was synthesized and characterized by spectroscopy and elemental analysis. The crystal structure was determined from single-crystal X-ray diffraction data. It crystallizes in the orthorhombic space group, P 212121, with unit cell dimensions a = 8.9443(10) Å, b = 9.7147(11) Å, and c = 13.8016(16) Å. The dihedral angle between the 2 aromatic rings is 82.32(4)\circ. The N2 and N3 nitro groups are oriented with respect to their attached phenyl rings at dihedral angles of 1.97(3)\circ and 15.73(3)\circ, respectively. The intramolecular C-H{\ldots}O hydrogen bond results in the formation of a non-planar 6-membered ring. In the crystal structure, intermolecular N-H...O hydrogen bonds seem to be effective in the stabilization of the structure, resulting in the formation of a 3-dimensional network.
___
- Makino, S.; Nakanishi, E.; Tsuji, T. Bull. Korean Chem. Soc. 2003, 24, 389-392.
- Makino, S.; Suzuki, N.; Nakanishi, E.; Tsuji, T. Synlett. 2001, 333-336.
- Ho, T.-I..; Chen, W.-S.; Hsu, C.-W.; Tsai, Y.-M..; Fang, J.-M. Heterocycles 2002, 57, 1501-1506.
- Zhichkin, P.; Kesicki, E.; Treiberg, J.; Bourdon, L.; M Ronsheim, M.; Ooi, H.C.; White, S.; Judkins A.; Fairfax, D. Org. Lett. 2007, 9, 1415-1418.
- Jackson, S.; DeGrado, W.; Dwivedi, A.; Parthasarathy, A.; Higley, A.; Krywko, J.; Rockwell, A., Markwalder, J., Wells, G., Wexler, R., Mousa, S. & Harlow, R. J. Am. Chem. Soc. 1994, 116, 3220-3230.
- Capdeville, R..; Buchdunger, E.; Zimmermann, J.; Matter, J. Nat. Rev. Drug Discovery 2002, 1, 493-502.
- Manley, P. W.; Furet, P.; Bold, G.; Bruggen, J.; Mestan, J.; Meyer, T.; Schnell, C. R.; Wood, J. J. Med. Chem. 2002, 45, 5687-5693.
- Igawa, H.; Nishimura, M.; Okada; K.; Nakamura; T. Jpn Kokai Tokkyo Koho. 1999, JP 11171848.
- Bruker, 2002, SMART (Ver. 5.62); SAINT (Ver. 6.02); SHELXTL (Ver. 6.10). Bruker AXS Inc.; Madison; Wisconsin; USA.